Add to ORKGSafety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of ag
To investigate the efficacy and safety of levetiracetam adjunctive therapy in childhood intractable ...
The aim of this multicentric, prospective and uncontrolled study was to evaluate the efficacy and s...
Levetiracetam given via intravenous administration has been shown to be an effective alternative in ...
article which permits unrestricted noncommercial use, provided the original work is properly cited
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
article which permits unrestricted noncommercial use, provided the original work is properly cited. ...
In the past decade, most studies on levetiracetam were conducted on patients aged4 years of age. The...
The efficacy and safety of levetiracetam (LEV) as adjunctive therapy were evaluated in 23 children (...
article which permits unrestricted noncommercial use, provided the original work is properly cited
This is an open access article. Unrestricted non-commercial use is permitted provided the original w...
Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of mer...
Context: Recently, new anti-epileptic drugs are marketed to be used as an add-on to the traditional ...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
In 2006, intravenous levetiracetam received US Food and Drug Administration (FDA) approval for adjun...
Epilepsy is a common neurological disorder in the pediatric population, affecting up to one percent ...
To investigate the efficacy and safety of levetiracetam adjunctive therapy in childhood intractable ...
The aim of this multicentric, prospective and uncontrolled study was to evaluate the efficacy and s...
Levetiracetam given via intravenous administration has been shown to be an effective alternative in ...
article which permits unrestricted noncommercial use, provided the original work is properly cited
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
article which permits unrestricted noncommercial use, provided the original work is properly cited. ...
In the past decade, most studies on levetiracetam were conducted on patients aged4 years of age. The...
The efficacy and safety of levetiracetam (LEV) as adjunctive therapy were evaluated in 23 children (...
article which permits unrestricted noncommercial use, provided the original work is properly cited
This is an open access article. Unrestricted non-commercial use is permitted provided the original w...
Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of mer...
Context: Recently, new anti-epileptic drugs are marketed to be used as an add-on to the traditional ...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
In 2006, intravenous levetiracetam received US Food and Drug Administration (FDA) approval for adjun...
Epilepsy is a common neurological disorder in the pediatric population, affecting up to one percent ...
To investigate the efficacy and safety of levetiracetam adjunctive therapy in childhood intractable ...
The aim of this multicentric, prospective and uncontrolled study was to evaluate the efficacy and s...
Levetiracetam given via intravenous administration has been shown to be an effective alternative in ...